Epigenetic Signature: A New Player as Predictor of Clinically Significant Prostate Cancer (PCa) in Patients on Active Surveillance (AS)
Widespread prostate-specific antigen (PSA) testing notably increased the number of prostate cancer (PCa) diagnoses. However, about 30% of these patients have low-risk tumors that are not lethal and remain asymptomatic during their lifetime. Overtreatment of such patients may reduce quality of life a...
Main Authors: | Matteo Ferro, Paola Ungaro, Amelia Cimmino, Giuseppe Lucarelli, Gian Maria Busetto, Francesco Cantiello, Rocco Damiano, Daniela Terracciano |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/18/6/1146 |
Similar Items
-
MRI and Active Surveillance for Prostate Cancer
by: Angelo Porreca, et al.
Published: (2020-08-01) -
Implementation of Max Principle with PCA in image fusion for Surveillance and Navigation Application
by: Senthil Kumar Sadhasivam, et al.
Published: (2011-07-01) -
The Impact of Caloric Restriction on the Epigenetic Signatures of Aging
by: Noémie Gensous, et al.
Published: (2019-04-01) -
Behavioral Epigenetics: Perspectives Based on Experience-Dependent Epigenetic Inheritance
by: You-Yuan Pang, et al.
Published: (2019-08-01) -
Epigenetic signature of preterm birth in adult twins
by: Qihua Tan, et al.
Published: (2018-06-01)